These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization. Hu GJ, Wang RY, Han DS, Alter HJ, Shih JW. Vaccine; 1999 Aug 06; 17(23-24):3160-70. PubMed ID: 10462252 [Abstract] [Full Text] [Related]
24. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadière B, Dalba C, Klatzmann D, Bellier B. Vaccine; 2013 Mar 01; 31(11):1540-7. PubMed ID: 22634300 [Abstract] [Full Text] [Related]
26. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice]. Li L, Tian YJ, Shen H, Zhao XP, Yang DL. Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 01; 17(4):275-9. PubMed ID: 19403026 [Abstract] [Full Text] [Related]
27. Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag. Sun W, Li Q, Zhu D, Feng J, Zhuang Z, Sun X, Xiao G, Duan Y. J Med Virol; 2015 Dec 01; 87(12):2090-7. PubMed ID: 26010499 [Abstract] [Full Text] [Related]
28. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L. Antiviral Res; 2009 Oct 01; 84(1):23-30. PubMed ID: 19646486 [Abstract] [Full Text] [Related]
29. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice. Hitomi Y, McDonnell WM, Baker JR, Askari FK. Viral Immunol; 1995 Oct 01; 8(2):109-19. PubMed ID: 8825296 [Abstract] [Full Text] [Related]
30. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ. Proc Natl Acad Sci U S A; 2003 May 27; 100(11):6753-8. PubMed ID: 12748380 [Abstract] [Full Text] [Related]
34. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X. J Virol Methods; 2007 Apr 27; 141(1):41-8. PubMed ID: 17197041 [Abstract] [Full Text] [Related]
35. Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells. Ou-Yang P, Hwang LH, Tao MH, Chiang BL, Chen DS. J Med Virol; 2002 Mar 27; 66(3):320-8. PubMed ID: 11793383 [Abstract] [Full Text] [Related]
37. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens. Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, Brinster C, Baumert T, Nakano I, Fukuda Y, Liljeström P, Trépo C, Inchauspé G. Virology; 2000 Oct 25; 276(2):259-70. PubMed ID: 11040118 [Abstract] [Full Text] [Related]
39. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. Large MK, Kittlesen DJ, Hahn YS. J Immunol; 1999 Jan 15; 162(2):931-8. PubMed ID: 9916717 [Abstract] [Full Text] [Related]
40. DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV. Jin J, Yang JY, Liu J, Kong YY, Wang Y, Li GD. World J Gastroenterol; 2002 Jun 15; 8(3):505-10. PubMed ID: 12046080 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]